Camptocormia is defined as an abnormal flexion of the thoracolumbar spine of 45 degrees, or more, that typically increases during walking or standing and completely disappears in the supine position. Camptocormia may occur in patients with Parkinson's disease; when it does, it is usually associated with greater disease severity. Respiratory complications, which may be secondary to abnormal chest function, are one of the most frequent causes of death in patients with Parkinson's disease. No data on lung volumes are available for Parkinson's disease patients with camptocormia. The aim of this study was to evaluate the effect of camptocormia on lung function. Eleven patients with Parkinson's disease and camptocormia and ten age-matched healthy subjects underwent lung spirometry (in the standing position, inclining the trunk forward at approx. 45 degrees and supine) measurement of arterial oxygen-hemoglobin saturation and heart rate. We found that Parkinson's disease with camptocormia is not associated with major clinical changes in lung volumes. (C) 2013 Elsevier B.V. All rights reserved.
Effect of camptocormia on lung volumes in Parkinson's disease / Paolo, Marinelli; Colosimo, Carlo; Alessandro Maria, Ferrazza; DI STASIO, Flavio; Fabbrini, Giovanni; Palange, Paolo; Berardelli, Alfredo. - In: RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY. - ISSN 1569-9048. - 187:2(2013), pp. 164-166. [10.1016/j.resp.2013.03.008]
Effect of camptocormia on lung volumes in Parkinson's disease
COLOSIMO, Carlo;DI STASIO, FLAVIO;FABBRINI, Giovanni;PALANGE, Paolo;BERARDELLI, Alfredo
2013
Abstract
Camptocormia is defined as an abnormal flexion of the thoracolumbar spine of 45 degrees, or more, that typically increases during walking or standing and completely disappears in the supine position. Camptocormia may occur in patients with Parkinson's disease; when it does, it is usually associated with greater disease severity. Respiratory complications, which may be secondary to abnormal chest function, are one of the most frequent causes of death in patients with Parkinson's disease. No data on lung volumes are available for Parkinson's disease patients with camptocormia. The aim of this study was to evaluate the effect of camptocormia on lung function. Eleven patients with Parkinson's disease and camptocormia and ten age-matched healthy subjects underwent lung spirometry (in the standing position, inclining the trunk forward at approx. 45 degrees and supine) measurement of arterial oxygen-hemoglobin saturation and heart rate. We found that Parkinson's disease with camptocormia is not associated with major clinical changes in lung volumes. (C) 2013 Elsevier B.V. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
